Page 92 - 2023 Taiwan Food and Drug Administration Annual Report
P. 92

2023 Taiwan Food and
Drug Administration

Annual Report

    Section 2                                        ▍	Implementation Strategy

    The 10th                                         I. 	 In order to expand the domains and levels
    Anniversary on                                      involved in the Taiwan-Japan collaboration
    Joint Conference of                                 on medicinal products and medical
    Taiwan and Japan                                    devices and to address globalization
    on Medical Products                                 trends in the medical field, TFDA holds
    Regulation                                          meetings with industries every year,
                                                        to help directly communicate between
    ▍	Introduction of the Policy                        regulatory authorities and industries, and
                                                        also provide ideas on governing regulations
          In order to advance the collaboration         or administrative measures, and discuss
    between Taiwan and Japan on regulations of          further in the general assembly.
    medicinal products and medical devices, the
    Taiwan-Japan Relations Association and the       II.	 Taiwan and Japan exchange information
    Japan-Taiwan Exchange Association signed            on regulations and review experiences
    the “Framework Agreement on Collaboration           through official working groups such
    between Taiwan and Japan” on November               as new drugs, generic drugs, good
    5, 2013. Since then, the Joint Conference           clinical practice and good manufacturing
    of Taiwan and Japan on Medical Products             practice, non-prescription drugs, quality
    Regulation began under this collaboration           management systems, product registration,
    framework. Under the framework, TFDA,               information exchange, mutual visits, and
    Ministry of Health, Labour and Welfare              observations and learning from each other,
    (MHLW) and the Pharmaceuticals and                  and collaboration within the industry for
    Medical Devices Agency (PMDA) formed the            deepened substantial exchange.
    governmental working group that exchanges
    the latest regulations on medicinal policies in  ▍	Achievements and Benefits
    Taiwan and Japan. The parties take turns each
    year holding seminars on the bilateral side,     I. Taiwan-Japan interaction
    and 2022 is marked as the tenth anniversary.       and developments in medical
                                                       field

                                                     (I) Taiwan and Japan formed the preliminary
                                                          framework for collaboration in the

90
   87   88   89   90   91   92   93   94   95   96   97